Healgen Scientific
16 Panel Drug Test Screening Cup with EtG Fentanyl K2 and Tramadol 25/Box
Bulk discount rates
Below are the available bulk discount rates for each individual item when you purchase a certain amount
Quantity | Per Item |
1 - 3 | $150.00 |
4 - 7 | $144.00 |
8 - 11 | $142.50 |
12+ | $139.75 |
Description
Multi-Panel Drug Screening Test Cup 16-Panel with Etg Alcohol, Fentanyl, K2, Tramadol
This high quality drug test cup is an easy, fast, qualitative, competitive binding immunoassay method for screening without the need of instrumentation.
The Multi-Panel Drug Test Cup is a No Step, fully integrated self contained multi-drug screening cup. No tipping or turning required. Read results
in 5 minutes. This cup is a fast visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of up to 14 drug metabolites at specific cutoff levels in human urine.
Features & Benefits
- CE Marking - Meets all European Conformity Standards
- Sold in boxes of 25 tests
- New "Click Seal" cap!
- No step cup
- Up to 99% Accurate
- Dual scale Temperature Strip verifies if urine is "fresh" and not diluted
- Adheres to the SAMHSA Cutoff Levels
- Immediate Results
- Shelf-life up to 24 months
- New easy to open top for the confirmation lab
- FOR FORENSIC USE ONLY (FUO)
Fourteen Panel Configuration(s)
Item Number |
Drugs Tested |
Adulterants Tested |
HCDOAV-6164EF1KT |
AMP, BAR, BUP, BZO, COC, ETG500, FEN, K2,MDMA, MET, OPI, MTD, OXY, PCP, THC, TRA |
None |
HCDOAV-6165E3F1KT |
AMP, BAR, BUP, BZO, COC, ETG300, FEN, K2,MDMA, MET, OPI300, MTD, OXY, PCP, THC, TRA |
None |
SAMSHA Approved CLIA Waived Drug Panel Options
Drug Name |
Abbreviation |
Cutoff Level |
Minimum Detection Time in Urine* | Maximum Detection Time in Urine* |
Calibrator |
Amphetamine | AMP | 1000 ng/ml | 2-7 hours | 2-4 days | D-Amphetamine |
Barbiturates | BAR | 300 ng/ml | 2-4 hours | 1-3 weeks | Secobarbital |
Benzodiazepines | BZO / BZD | 300 ng/ml | 2-7 hours | 1-4 days | Benzoylecgonine |
Buprenorphine | BUP | 10 ng/ml | 2-3 hours | 1 day | Buprenorphine |
Cocaine | COC | 300 ng/ml | 1-4 hours | 2-4 days | Benzoylecgonine |
Ecstasy | MDMA | 500 ng/ml | 1-3 days | 1-2 days | D,L- Methylenedioxy-methamphetamine |
Marijuana | THC | 50 ng/ml | 2 hours | up to 40 days | 11-nor-Δ9-THC-9 COOH |
Methadone | MTD / MAD | 300 ng/ml | 3-8 hours | 1-3 days | Methadone |
Methamphetamine | mAMP / MET | 1000 ng/ml | 2-7 hours | 2-4 days | D-Methamphetamine |
Morphine | MOP / OPI-300 | 300 ng/ml | 2 hours | 2-3 days | Morphine |
Opiates | OPI | 2000 ng/ml | 2 hours | 2-3 days | Morphine |
Oxycodone | OXY | 100 ng/ml | 1-3 hours | 1-2 days | Oxycodone |
Phencyclidine | PCP | 25 ng/ml | 4-6 hours | 7-14 days | Phencyclidine |
Propoxyphene | PPX | 300 ng/ml | 1-2 days | N/A | Propoxyphene |
Tricyclic Antidepressants | TCA | 1000 ng/ml | 8-12 hours | 2-7 days | Nortriptyline |
* Detection times are not guaranteed. Reference configuration above for included drug panels. |
Optional CLIA Waived Drug Panels (call 404-840-8900 for more information)
Drug Name |
Abbreviation |
Cutoff Level |
Minimum Detection Time in Urine* | Maximum Detection Time in Urine* |
Calibrator |
Amphetamine | AMP | 500 ng/ml | 2-7 hours | 2-4 days | D-Amphetamine |
Cocaine | COC | 150 ng/ml | 1-4 hours | 2-4 days | Benzoylecgonine |
EDDP | EDDP | 300 ng/ml | 1-4 hours | 2-4 days | 2-Ethylidene-1,5-dimethyl-3,3-dipheylpyrrolidine |
Methamphetamine | mAMP / MET | 500 ng/ml | 2-7 hours | 2-4 days | D-Methamphetamine |
* Detection times are not guaranteed. Reference configuration above for included drug panels. |
TransMed Company offers the following optional Forensic Use Only (FUO) Panels: K2/Spice, EtG, Tramadol and Fenytanyl
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed
analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment
should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.